CymitQuimica logo

CAS 354813-19-7

:

Balicatib

Description:
Balicatib, with the CAS number 354813-19-7, is a chemical compound that functions primarily as a selective inhibitor of cathepsin K, an enzyme involved in bone resorption. This characteristic makes Balicatib of particular interest in the treatment of osteoporosis and other bone-related disorders, as it helps to reduce bone loss by inhibiting the activity of osteoclasts, the cells responsible for bone degradation. The compound is typically characterized by its specific molecular structure, which allows it to bind effectively to the active site of cathepsin K. Balicatib has been studied for its pharmacokinetic properties, including absorption, distribution, metabolism, and excretion, which are crucial for determining its efficacy and safety profile in clinical settings. Additionally, its potential side effects and interactions with other medications are important considerations in its therapeutic use. Overall, Balicatib represents a targeted approach in the management of conditions associated with excessive bone resorption.
Formula:C23H33N5O2
InChI:InChI=1S/C23H33N5O2/c1-2-14-27-15-17-28(18-16-27)20-8-6-19(7-9-20)21(29)26-23(10-4-3-5-11-23)22(30)25-13-12-24/h6-9H,2-5,10-11,13-18H2,1H3,(H,25,30)(H,26,29)
InChI key:LLCRBOWRJOUJAE-UHFFFAOYSA-N
SMILES:CCCN1CCN(CC1)C2=CC=C(C=C2)C(=O)NC3(CCCCC3)C(=O)NCC#N
Synonyms:
  • Aae-581
Found 6 products.